15 Fastest Growing Biotech Companies in the US
In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest...
Posts Tagged ‘NASDAQ:RARE’
Hedge Fund and Insider Trading News: Crispin Odey, Bill Ackman, Steve Cohen, Christopher Hohn, Ultragenyx Pharmaceutical Inc (RARE), Compass Diversified Holdings (CODI), and More
Odey’s Slump Deepens as His Hedge Fund Loses Another 30.5% (Bloomberg) Crispin Odey’s flagship hedge fund lost money again in 2020, deepening the...
Is RARE A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred...
Hedge Fund and Insider Trading News: Ray Dalio, Ken Griffin, Bill Miller, Bill Ackman, Ultragenyx Pharmaceutical Inc (RARE), Caterpillar Inc. (CAT), and More
Bill Miller’s Fund Crushed the Market for a Record 15 Straight Years. Here’s How the Legendary Investor recently Applied His Long-term Approach...
Here is What Hedge Funds Think About Ultragenyx Pharmaceutical Inc (RARE)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However...
Did Hedge Funds Make The Right Call On Ultragenyx Pharmaceutical Inc (RARE) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors...
Ultragenyx Pharmaceutical Inc (RARE): Hedge Funds In Wait-and-See Mode
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Hedge Fund and Insider Trading News: David Gerstenhaber, Bill Ackman, Visium Asset Management, Citadel LLC, Egerton Capital, Ultragenyx Pharmaceutical Inc (RARE), II-VI, Inc. (IIVI), and More
Judge Tosses Hedge Fund Visium’s Lawsuit Against Portfolio Manager’s Widow (The Wall Street Journal) A judge has dismissed a lawsuit brought by a...
Hedge Funds Were Selling Ultragenyx Pharmaceutical Inc (RARE) Before The Coronavirus
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Do Hedge Funds Love Ultragenyx Pharmaceutical Inc (RARE)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Were Hedge Funds Right About Dumping Ultragenyx Pharmaceutical Inc (RARE)?
“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively...
Hedge Fund and Insider Trading News: John Paulson, Daniel Loeb, Tom Steyer, GoldenTree Asset Management, Fox Factory Holding Corp (FOXF), Silicon Laboratories (SLAB), and More
Billionaire John Paulson to Host NYC Fundraiser for Trump (Fox Business) When President Trump returns to New York City to speak at the United Nations...
Here’s What Hedge Funds Think About Ultragenyx Pharmaceutical Inc (RARE)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly...
Did Hedge Funds Drop The Ball On Ultragenyx Pharmaceutical Inc (RARE) ?
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research...
Hedge Funds Are Crazy About Ultragenyx Pharmaceutical Inc (RARE)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However...
Hedge Funds Are Dumping Ultragenyx Pharmaceutical Inc (RARE)
We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S...
Here’s What We’re Looking For From Ultragenyx Pharmaceutical Inc (RARE)
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) just announced that it has completed enrollment in its pivotal study of its lead rickets candidate, and given...
Is Ultragenyx Pharmaceutical Inc (RARE) Going to Burn These Hedge Funds?
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down...
